The relationship between angiotensin converting enzyme gene I/D polymorphism and QT dispersion in patients with hypertrophic cardiomyopathy

被引:9
|
作者
Kaya, Cansin Tulunay [1 ]
Gurlek, Adalet [1 ]
Altin, Timucin [1 ]
Kilickap, Mustafa [1 ]
Karabulut, Halil Gurhan [1 ]
Turhan, Sibel [1 ]
Ozcan, Ozgur [1 ]
Bokesoy, Isik [1 ]
Oral, Dervis [1 ]
Erol, Cetin [1 ]
机构
[1] Ankara Univ, Tip Fak, Kardiyol ABD, Sch Med, TR-06100 Ankara, Turkey
关键词
ACE gene I/D polymorphism; arrhythmia; corrected QT dispersion; hypertrophic cardiomyopathy; QT dispersion; LEFT-VENTRICULAR HYPERTROPHY; INSERTION DELETION POLYMORPHISM; ABNORMALITIES; ENHANCEMENT; ARRHYTHMIAS; MORTALITY; GENOTYPE; INTERVAL; DISEASE; DEATH;
D O I
10.1177/1470320310368190
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Introduction: Hypertrophic cardiomyopathy (HCM) is characterized by disorganized myocardial architecture, and may cause ventricular arrhythmias and sudden death. The angiotensin-converting enzyme (ACE) with two deletion alleles (DD genotype) has been proposed to be associated with increased myocardial collagen content. We evaluated QT dispersion (QTd), which reflects regional differences in ventricular repolarization, in HCM patient and controls among the three different ACE genotypes. Materials and methods: Sixty-three patients with HCM and 20 healthy subjects were included in the study. QT parameters were measured from 12 lead electrocardiograms. ACE genotypes were determined from the DNA extracted from peripheral blood by a polymerase chain reaction (PCR) method. QT parameters were compared among the three ACE genotypes both in HCM patients and controls. Results: Median ages were similar in HCM and control groups. QTd and corrected QTd (QTcd) were significantly greater in the HCM group compared with the controls. The frequencies of each genotype were similar in both groups. Although QTd and QTcd did not differ among the three genotypes in the control subjects, they were significantly greater in patients with DD genotype compared with other genotypes in the HCM group. Conclusion: QTd and QTcd are increased in patients with HCM, especially in those with the DD genotype.
引用
收藏
页码:192 / 197
页数:6
相关论文
共 50 条
  • [31] Insertion/deletion (I/D) polymorphism in the angiotensin converting enzyme (ACE) gene
    Berg, K
    VASCULAR ENDOTHELIUM: PHARMACOLOGIC AND GENETIC MANIPULATIONS, 1998, 294 : 57 - 73
  • [32] Angiotensin-converting enzyme I/D gene polymorphism in multiple sclerosis
    Stankovic, A.
    Gasparovic, I.
    Peterlin, B.
    Klupka-Saric, I.
    Zivkovic, M.
    Cizmarevic, N. Starcevic
    Lovrecic, L.
    Sinanovic, O.
    Dincic, E.
    Perkovic, O.
    Rudolf, G.
    Vidovic, M.
    Stojkovic, Lj
    Lavtar, P.
    Sehanovic, A.
    Ristic, S.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S115 - S115
  • [33] Angiotensin-converting enzyme gene I/D polymorphism in malignant hypertension
    Stefansson, B
    Ricksten, A
    Rymo, L
    Aurell, M
    Herlitz, H
    BLOOD PRESSURE, 2000, 9 (2-3) : 104 - 109
  • [34] Angiotensin-converting enzyme gene I/D polymorphism and renal disease
    Gerjan Navis
    Frank G.H. van der Kleij
    Dick de Zeeuw
    Paul E. de Jong
    Journal of Molecular Medicine, 1999, 77 : 781 - 791
  • [35] The Relationship Between Angiotensin-Converting Enzyme Gene I/D Polymorphism and Psoriasis, Including Psoriasis with Comorbid Hypertension and Diabetes
    Liu, Jiayun
    Sun, Rui
    Gao, Guomin
    Zhang, Mogen
    Fan, Huiping
    Ma, Xiaonan
    Yu, Yanhong
    Yuan, Yanmei
    Zhang, Lulu
    Niu, Changying
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17
  • [36] Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with hypertension
    Jeng, JR
    Shieh, SM
    Harn, HJ
    Lee, MMS
    Sheu, WHH
    Jeng, CY
    JOURNAL OF HYPERTENSION, 1997, 15 (09) : 963 - 968
  • [37] Pharmacogenetic interactions between angiotensin-converting enzyme insertion/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy
    Nagai, T.
    Ogimoto, A.
    Okayama, H.
    Ohtsuka, T.
    Shigematsu, Y.
    Hamada, M.
    Miki, T.
    Higaki, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 477 - 477
  • [38] Pharmacogenetic Interactions Between Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Response to Cibenzoline in Patients With Hypertrophic Obstructive Cardiomyopathy
    Ogimoto, Akiyoshi
    Okayama, Hideki
    Nagai, Takayuki
    Ohtsuka, Tomoaki
    Suzuki, Jun
    Inoue, Katsuji
    Nishimura, Kazuhisa
    Saito, Makoto
    Shigematsu, Yuji
    Hamada, Mareomi
    Miki, Tetsuro
    Higaki, Jitsuo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 55 (05) : 506 - 510
  • [39] The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation
    Tesson, F
    Dufour, C
    Moolman, JC
    Carrier, L
    AlMahdawi, S
    Chojnowska, L
    Dubourg, O
    Soubrier, F
    Brink, P
    Komajda, M
    Guicheney, P
    Schwartz, K
    Feingold, J
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (02) : 831 - 838
  • [40] Relationship between angiotensin I converting enyne gene polymorphism and diabetic nephropathy
    Hang, TZ
    Zhi, LM
    DIABETOLOGIA, 1997, 40 : 2057 - 2057